The use of opioids at the end of life: the knowledge level of Dutch physicians as a potential barrier to effective pain management
Tóm tắt
Pain is still one of the most frequently occurring symptoms at the end of life, although it can be treated satisfactorily in most cases if the physician has adequate knowledge. In the Netherlands, almost 60% of the patients with non-acute illnesses die at home where end of life care is coordinated by the general practitioner (GP); about 30% die in hospitals (cared for by clinical specialists), and about 10% in nursing homes (cared for by elderly care physicians). The research question of this study is: what is the level of knowledge of Dutch physicians concerning pain management and the use of opioids at the end of life? A written questionnaire was sent to a random sample of physicians of specialties most often involved in end of life care in the Netherlands. The questionnaire was completed by 406 physicians, response rate 41%. Almost all physicians were aware of the most basal knowledge about opioids, e.g. that it is important for treatment purposes to distinguish nociceptive from neuropathic pain (97%). Approximately half of the physicians (46%) did not know that decreased renal function raises plasma concentration of morphine(-metabolites) and 34% of the clinical specialists erroneously thought opioids are the favoured drug for palliative sedation. Although 91% knew that opioids titrated against pain do not shorten life, 10% sometimes or often gave higher dosages than needed with the explicit aim to hasten death. About half felt sometimes or often pressured by relatives to hasten death by increasing opioiddosage. The large majority (83%) of physicians was interested in additional education about subjects related to the end of life, the most popular subject was opioid rotation (46%). Although the basic knowledge of physicians was adequate, there seemed to be a lack of knowledge in several areas, which can be a barrier for good pain management at the end of life. From this study four areas emerge, in which it seems likely that an improvement can improve the quality of pain management at the end of life for many patients in the Netherlands: 1)palliative sedation; 2)expected effect of opioids on survival; and 3) opioid rotation.
Tài liệu tham khảo
Fairchild A: Under-treatment of cancer pain. Curr Opin Support Palliat Care. 2010, 4: 11-15. 10.1097/SPC.0b013e328336289c.
Potter J, Hami F, Bryan T, Quigley C: Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med. 2003, 17: 310-314. 10.1191/0269216303pm760oa.
Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A: Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007, 34: 94-104. 10.1016/j.jpainsymman.2006.10.015.
Borgsteede SD, Deliens L, Beentjes B, Schellevis F, Stalman WA, van Eijk JT, Van der Wal G: Symptoms in patients receiving palliative care: a study on patient-physician encounters in general practice. Palliat Med. 2007, 21: 417-423. 10.1177/0269216307079821.
Grossman SA, Dunbar EM, Nesbit SA: Cancer pain management in the 21st century. Oncology (Williston Park). 2006, 20: 1333-1339.
Enting RH, Oldenmenger WH, Van Gool AR, van der Rijt CC, Sillevis Smitt PA: The effects of analgesic prescription and patient adherence on pain in a dutch outpatient cancer population. J Pain Symptom Manage. 2007, 34: 523-531. 10.1016/j.jpainsymman.2007.01.007.
Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V: Family perspectives on end-of-life care at the last place of care. JAMA. 2004, 291: 88-93. 10.1001/jama.291.1.88.
Health Council of the Netherlands: European primary care. 2004, The Hague: Health Council of the Netherlands, 20E
Francke AL, Willems DL: Palliatieve zorg vandaag en morgen. [Palliative care today and tomorrow]. 2000, Maarssen: Elsevier gezondheidszorg, 1
Mistiaen P, Van Ruth L, Francke AL: Monitor Palliatieve Zorg [Monitor Palliative Care]. 2006, Utrecht: NIVEL
Van der Heide A, Onwuteaka-Philipsen BD, Rurup ML, Buiting HM, van Delden JJ, Hanssen-de Wolf JE, Janssen AG, Pasman HR, Rietjens JA, Prins CJ, Deerenberg IM, Gevers JK, van der Maas PJ, Van der Wal G: End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med. 2007, 356: 1957-1965. 10.1056/NEJMsa071143.
Ribbe MW, Ljunggren G, Steel K, Topinkova E, Hawes C, Ikegami N, Henrard JC, Jonnson PV: Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing. 1997, 26 (Suppl 2): 3-12.
Brandt HE, Deliens L, Ooms ME, van der Steen JT, Van der Wal G, Ribbe MW: Symptoms, signs, problems, and diseases of terminally ill nursing home patients: a nationwide observational study in the Netherlands. Arch Intern Med. 2005, 165: 314-320. 10.1001/archinte.165.3.314.
Borgsteede SD, Deliens L, Van der Wal G, Francke AL, Stalman WA, van Eijk JT: Interdisciplinary cooperation of GPs in palliative care at home: a nationwide survey in The Netherlands. Scand J Prim Health Care. 2007, 25: 226-231. 10.1080/02813430701706501.
Kuin A, Courtens AM, Deliens L, Vernooij-Dassen MJ, van Zuylen L, van der Linden B, Van der Wal G: Palliative care consultation in The Netherlands: a nationwide evaluation study. J Pain Symptom Manage. 2004, 27: 53-60. 10.1016/j.jpainsymman.2003.06.001.
Carr DB: The development of national guidelines for pain control: synopsis and commentary. Eur J Pain. 2001, 5 (Suppl A): 91-98. 10.1053/eujp.2001.0288.
McQuay H: Opioids in pain management. Lancet. 1999, 353: 2229-2232. 10.1016/S0140-6736(99)03528-X.
Estfan B, Mahmoud F, Shaheen P, Davis MP, Lasheen W, Rivera N, Legrand SB, Lagman RL, Walsh D, Rybicki L: Respiratory function during parenteral opioid titration for cancer pain. Palliat Med. 2007, 21: 81-86. 10.1177/0269216307077328.
Elliott TE, Elliott BA: Physician attitudes and beliefs about use of morphine for cancer pain. J Pain Symptom Manage. 1992, 7: 141-148. 10.1016/S0885-3924(06)80005-9.
Whipple JK, Lewis KS, Quebbeman EJ, Wolff M, Gottlieb MS, Medicus-Bringa M, Hartnett KR, Graf M, Ausman RK: Analysis of pain management in critically ill patients. Pharmacotherapy. 1995, 15: 592-599.
Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V: Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001, 84: 587-593. 10.1054/bjoc.2001.1680.
Sykes N, Thorns A: The use of opioids and sedatives at the end of life. Lancet Oncol. 2003, 4: 312-318. 10.1016/S1470-2045(03)01079-9.
Vitetta L, Kenner D, Sali A: Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life. Am J Hosp Palliat Care. 2005, 22: 465-473.
Gallagher R, Hawley P, Yeomans W: A survey of cancer pain management knowledge and attitudes of British Columbian physicians. Pain Res Manag. 2004, 9: 188-194.
Rurup ML, Borgsteede SD, Van der Heide A, van der Maas PJ, Onwuteaka-Philipsen BD: Trends in the Use of Opioids at the End of Life and the Expected Effects on Hastening Death. J Pain Symptom Manage. 2009, 37: 144-55. 10.1016/j.jpainsymman.2008.02.010.
Bouvy ML, Buurma H, Egberts TC: Laxative prescribing in relation to opioid use and the influence of pharmacy-based intervention. J Clin Pharm Ther. 2002, 27: 107-110. 10.1046/j.1365-2710.2002.00385.x.
Borgsteede SD, Deliens L, Zuurmond WW, Schellevis FG, Willems DL, Van der Wal G, van Eijk JT: Prescribing of pain medication in palliative care. A survey in general practice. Pharmacoepidemiol Drug Saf. 2009, 18: 16-23. 10.1002/pds.1678.
Niemi-Murola L, Nieminen JT, Kalso E, Poyhia R: Medical undergraduate students' beliefs and attitudes toward pain: how do they mature?. Eur J Pain. 2007, 11: 700-706. 10.1016/j.ejpain.2006.12.001.
Vallerand AH, Collins-Bohler D, Templin T, Hasenau SM: Knowledge of and barriers to pain management in caregivers of cancer patients receiving homecare. Cancer Nurs. 2007, 30: 31-37. 10.1097/00002820-200701000-00006.
Lambert K, Oxberry S, Hulme CW, Saharia K, Rigby AS, Johnson MJ: Knowledge of attitudes to opioids in palliative care patients. Palliat Med. 2007, 21: 721-722. 10.1177/0269216307083370.
Bosch F, Banos JE: Religious beliefs of patients and caregivers as a barrier to the pharmacologic control of cancer pain. Clin Pharmacol Ther. 2002, 72: 107-111. 10.1067/mcp.2002.126180.
Potter M, Schafer S, Gonzalez-Mendez E, Gjeltema K, Lopez A, Wu J, Pedrin R, Cozen M, Wilson R, Thom D, Croughan-Minihane M: Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001, 50: 145-151.
Hollen CJ, Hollen CW, Stolte K: Hospice and hospital oncology unit nurses: a comparative survey of knowledge and attitudes about cancer pain. Oncol Nurs Forum. 2000, 27: 1593-1599.
Larue F, Fontaine A, Brasseur L: Evolution of the French public's knowledge and attitudes regarding postoperative pain, cancer pain, and their treatments: two national surveys over a six-year period. Anesth Analg. 1999, 89: 659-664. 10.1097/00000539-199909000-00023.
de Leon-Casasola OA: Current developments in opioid therapy for management of cancer pain. Clin J Pain. 2008, 24 (Suppl 10): S3-S7.
Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V: Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001, 19: 2542-2554.
Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA: Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999, 79: 15-20. 10.1016/S0304-3959(98)00138-9.
Thompson AR, Ray JB: The importance of opioid tolerance: a therapeutic paradox. J Am Coll Surg. 2003, 196: 321-324. 10.1016/S1072-7515(02)01800-8.
Angst MS, Clark JD: Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006, 104: 570-587. 10.1097/00000542-200603000-00025.
Mao J: Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002, 100: 213-217. 10.1016/S0304-3959(02)00422-0.
Davis MP, Shaiova LA, Angst MS: When opioids cause pain. J Clin Oncol. 2007, 25: 4497-4498. 10.1200/JCO.2006.09.1462.
Mercadante S, Ferrera P, Villari P, Arcuri E: Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage. 2003, 26: 769-775. 10.1016/S0885-3924(03)00258-6.
Davis MP, Lasheen W, Gamier P: Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know. Oncology (Williston Park). 2007, 21: 1229-1238.
Marcou TA, Marque S, Mazoit JX, Benhamou D: The median effective dose of tramadol and morphine for postoperative patients: a study of interactions. Anesth Analg. 2005, 100: 469-474. 10.1213/01.ANE.0000142121.24052.25.
Hagle ME, Lehr VT, Brubakken K, Shippee A: Respiratory depression in adult patients with intravenous patient-controlled analgesia. Orthop Nurs. 2004, 23: 18-27. 10.1097/00006416-200401000-00007.
Macintyre PE: Safety and efficacy of patient-controlled analgesia. Br J Anaesth. 2001, 87: 36-46. 10.1093/bja/87.1.36.
Ko S, Goldstein DH, VanDenKerkhof EG: Definitions of "respiratory depression" with intrathecal morphine postoperative analgesia: a review of the literature. Can J Anaesth. 2003, 50: 679-688. 10.1007/BF03018710.
Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M: Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer. 2004, 12: 432-440. 10.1007/s00520-004-0629-y.
Thorns A, Sykes N: Opioid use in last week of life and implications for end-of-life decision-making. Lancet. 2000, 356: 398-399. 10.1016/S0140-6736(00)02534-4.
Morita T, Tsunoda J, Inoue S, Chihara S: Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage. 2001, 21: 282-289. 10.1016/S0885-3924(01)00258-5.
Bercovitch M, Adunsky A: Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?. Cancer. 2004, 101: 1473-1477. 10.1002/cncr.20485.
Good PD, Ravenscroft PJ, Cavenagh J: Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J. 2005, 35: 512-517. 10.1111/j.1445-5994.2005.00888.x.
Commissie landelijke richtlijn palliatieve sedatie: KNMG richtlijn "Palliatieve sedatie". 2009
Elliott TE, Murray DM, Elliott BA, Braun B, Oken MM, Johnson KM, Post-White J, Lichtblau L: Physician knowledge and attitudes about cancer pain management: a survey from the Minnesota cancer pain project. J Pain Symptom Manage. 1995, 10: 494-504. 10.1016/0885-3924(95)00100-D.
Mercadante S, Arcuri E: Opioids and renal function. J Pain. 2004, 5: 2-19. 10.1016/j.jpain.2003.09.007.
Arnold RM, Verrico P, Davison SN: Opioid use in renal failure #161. J Palliat Med. 2007, 10: 1403-1404. 10.1089/jpm.2007.9840.
KNMP/WINAp: Standaard Euthanatica. Toepassing en bereiding [Standard for Euthanatics. Preparation and use]. 2007, Den Haag: KNMP
Knotkova H, Fine PG, Portenoy RK: Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage. 2009, 38: 426-439. 10.1016/j.jpainsymman.2009.06.001.
Holdsworth MT, Forman WB, Killilea TA, Nystrom KM, Paul R, Brand SC, Reynolds R: Transdermal fentanyl disposition in elderly subjects. Gerontology. 1994, 40: 32-37. 10.1159/000213572.
Gupta SK, Hwang S, Southam M, Sathyan G: Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet. 2005, 44 (Suppl 1): 25-32.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-684X/9/23/prepub